Published in J Hypertens on June 01, 1989
Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med (1999) 4.85
The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med (2000) 4.81
Cystatin for estimation of glomerular filtration rate? Lancet (2000) 2.80
Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome. Nat Med (2001) 2.46
Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure? Circ Res (2001) 2.38
Contribution of adverse drug reactions to hospital admission of older patients. Age Ageing (2000) 2.29
Chronic myocardial infarction in the mouse: cardiac structural and functional changes. Cardiovasc Res (1999) 2.25
The infarcted myocardium: simply dead tissue, or a lively target for therapeutic interventions. Cardiovasc Res (1999) 2.06
Real-time imaging of apoptotic cell-membrane changes at the single-cell level in the beating murine heart. Nat Med (2001) 1.91
Cardiac renin and angiotensins. Uptake from plasma versus in situ synthesis. Hypertension (1994) 1.87
Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521. Br J Clin Pharmacol (1982) 1.81
Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system. Br J Ophthalmol (1996) 1.74
Estrogen modulates AT1 receptor gene expression in vitro and in vivo. Circulation (1998) 1.69
Volume regulation in children with early relapse of minimal-change nephrosis with or without hypovolaemic symptoms. Lancet (1995) 1.56
The human E48 antigen, highly homologous to the murine Ly-6 antigen ThB, is a GPI-anchored molecule apparently involved in keratinocyte cell-cell adhesion. J Cell Biol (1995) 1.51
Do older hospital patients recognize adverse drug reactions? Age Ageing (2000) 1.49
Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1997) 1.45
Support for adrenaline-hypertension hypothesis: 18 hour pressor effect after 6 hours adrenaline infusion. Lancet (1988) 1.40
Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Circulation (1997) 1.40
Dermal uptake of polycyclic aromatic hydrocarbons after hairwash with coal-tar shampoo. Lancet (1994) 1.40
[Hypertension caused by arterial fibromuscular dysplasia]. Ned Tijdschr Geneeskd (1994) 1.39
Dynamics of cardiac wound healing following myocardial infarction: observations in genetically altered mice. Acta Physiol Scand (2001) 1.37
Angiotensin levels in the eye. Invest Ophthalmol Vis Sci (1994) 1.36
Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy. J Clin Endocrinol Metab (1989) 1.35
Opposite effects of captopril on angiotensin I-converting enzyme 'activity' and 'concentration'; relation between enzyme inhibition and long-term blood pressure response. Clin Sci (Lond) (1981) 1.31
Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans. J Hypertens (1998) 1.28
Adverse drug reactions in elderly patients as contributing factor for hospital admission: cross sectional study. BMJ (1997) 1.27
Angiotensin I-to-II conversion in the human renal vascular bed. J Hypertens (1998) 1.26
Antihypertensive effect of propranolol in conscious spontaneously hypertensive rats: central hemodynamics, plasma volume, and renal function during beta-blockade with propranolol. J Cardiovasc Pharmacol (1983) 1.25
Short-term and long-term blood pressure and heart rate variability in the mouse. Am J Physiol Regul Integr Comp Physiol (2000) 1.25
Altered flow-induced arterial remodeling in vimentin-deficient mice. Arterioscler Thromb Vasc Biol (2000) 1.23
Inactive renin in human plasma. Lancet (1976) 1.22
Evidence for a novel angiotensin II receptor involved in angiogenesis in chick embryo chorioallantoic membrane. Am J Physiol (1993) 1.22
Cardiomyocyte death induced by myocardial ischemia and reperfusion: measurement with recombinant human annexin-V in a mouse model. Circulation (2000) 1.18
Effects of an angiotensin-converting enzyme inhibitor (captopril) on blood pressure in anephric subjects. Br Med J (1980) 1.17
Increase in serum prorenin precedes onset of microalbuminuria in patients with insulin-dependent diabetes mellitus. Diabetologia (1999) 1.14
Mannose 6-phosphate receptor-mediated internalization and activation of prorenin by cardiac cells. Hypertension (1997) 1.14
Failure of atriopeptin II to cause arterial vasodilation in the conscious rat. Circ Res (1985) 1.11
Markers of apoptosis in cardiovascular tissues: focus on Annexin V. Cardiovasc Res (2000) 1.10
Microvascular alterations in adult conscious spontaneously hypertensive rats. Hypertension (1990) 1.10
Reduction of blood pressure with oral magnesium supplementation in women with mild to moderate hypertension. Am J Clin Nutr (1994) 1.09
Matrix Gla protein accumulates at the border of regions of calcification and normal tissue in the media of the arterial vessel wall. Biochem Biophys Res Commun (2001) 1.09
Activation of inactive plasma renin by plasma and tissue kallikreins. Clin Sci (Lond) (1979) 1.09
Identification and quantification of renin and prorenin in the bovine eye. Endocrinology (1990) 1.08
Control of enzymatically inactive renin in man under various pathological conditions: implications for the interpretation of renin measurements in peripheral and renal venous plasma. Clin Sci Mol Med (1978) 1.07
Possible role of nitric oxide-cyclic GMP pathway in object recognition memory: effects of 7-nitroindazole and zaprinast. Eur J Pharmacol (1997) 1.06
Effects of selective and nonselective beta-agonists on plasma potassium and norepinephrine. J Cardiovasc Pharmacol (1984) 1.06
DNA synthesis in the non-infarcted cardiac interstitium after left coronary artery ligation in the rat: effects of captopril. J Mol Cell Cardiol (1991) 1.05
Beta-catenin, an inducer of uncontrolled cell proliferation and migration in malignancies, is localized in the cytoplasm of vascular endothelium during neovascularization after myocardial infarction. Am J Pathol (2000) 1.05
Splint renal function after captopril in unilateral renal artery stenosis. Br Med J (Clin Res Ed) (1984) 1.04
Alpha 1-adrenoreceptor blockade reduces the angiotensin II-induced vascular smooth muscle cell DNA synthesis in the rat thoracic aorta and carotid artery. Circ Res (1992) 1.03
Cardiovascular phenotyping in mice. Cardiovasc Res (1998) 1.02
Pulmonary artery remodeling differs in hypoxia- and monocrotaline-induced pulmonary hypertension. Am J Respir Crit Care Med (1998) 1.02
Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response? J Hypertens (1992) 1.01
Structural alterations in heart valves during left ventricular pressure overload in the rat. Lab Invest (1994) 1.01
Cardiac remodeling after myocardial infarction is impaired in IGF-1 deficient mice. Cardiovasc Res (2001) 1.00
Asynchronous changes in prorenin and renin secretion after captopril in patients with renal artery stenosis. Hypertension (1983) 1.00
A homologue of Drosophila tissue polarity gene frizzled is expressed in migrating myofibroblasts in the infarcted rat heart. Nat Med (1997) 0.99
Pharmacological interaction between pancuronium bromide and anaesthetics. Eur J Pharmacol (1968) 0.98
Analysis of acenocoumarin and its amino and acetamido metabolites in body fluids by high-performance liquid chromatography. J Chromatogr (1983) 0.98
An intrinsic factor XII- prekallikrein-dependent pathway activates the human plasma renin-angiotensin system. Nature (1979) 0.98
Uptake and proteolytic activation of prorenin by cultured human endothelial cells. J Hypertens (1999) 0.98
The microcirculation and hypertension. J Hypertens Suppl (1992) 0.97
AT2 receptor blockade reduces cardiac interstitial cell DNA synthesis and cardiac function after rat myocardial infarction. J Mol Cell Cardiol (1998) 0.97
Human liver microsomal metabolism of the enantiomers of warfarin and acenocoumarol: P450 isozyme diversity determines the differences in their pharmacokinetics. Br J Pharmacol (1993) 0.96
Intestinal flora is not an intermediate in the phylloquinone-menaquinone-4 conversion in the rat. Biochim Biophys Acta (1998) 0.95
Increased expression of fibronectin isoforms after myocardial infarction in rats. J Mol Cell Cardiol (1997) 0.95
Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts. Circulation (1993) 0.95
Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension. Hypertension (1990) 0.94
Plasma semicarbazide-sensitive amine oxidase activity is elevated in diabetes mellitus and correlates with glycosylated haemoglobin. Clin Sci (Lond) (1995) 0.94
High plasma prorenin in diabetes mellitus and its correlation with some complications. J Clin Endocrinol Metab (1990) 0.93
Lack of effect of cimetidine on pharmacodynamics and kinetics of single oral doses of R- and S-acenocoumarol. Eur J Clin Pharmacol (1986) 0.93
DDAVP (1-desamino-8-D-arginine vasopressin): an antagonist of the pressor action of endogenous vasopressin? J Hypertens Suppl (1983) 0.93
Expression and localization of renin and angiotensinogen in rat heart after myocardial infarction. Am J Physiol (1996) 0.93
Transmural changes in mast cell density in rat heart after infarct induction in vivo. J Pathol (1995) 0.92
Warfarin resistance. Vitamin K epoxide reductase of Scottish resistance genes is not irreversibly blocked by warfarin. Biochem Pharmacol (1987) 0.90
Clinical pharmacokinetics: a comprehensive system for therapeutic drug monitoring and prescribing. Br Med J (Clin Res Ed) (1984) 0.90
The role of the baroreceptor reflex in the cardiovascular effects of propranolol in the conscious spontaneously hypertensive rat. Clin Sci (Lond) (1979) 0.90
Active metabolites of acenocoumarol: do they contribute to the therapeutic effect? Br J Clin Pharmacol (1983) 0.89
A simplified radioassay method of dihydropteroate synthetase activity in Escherichia coli and its application for an inhibition study of p-aminobenzoi acid derivatives. Anal Biochem (1973) 0.89
Haemodynamic profile of captopril treatment in various forms of hypertension. Eur J Clin Pharmacol (1981) 0.89
Endothelin and active renin levels in essential hypertension and hypertension with renal artery stenosis before and after percutaneous transluminal renal angioplasty. J Hypertens (1997) 0.89
Immunoreactive renin, prorenin, and enzymatically active renin in plasma during pregnancy and in women taking oral contraceptives. J Clin Endocrinol Metab (1986) 0.89
Effects of chemical sympathectomy on angiotensin II-induced neointimal growth in the balloon-injured rat carotid artery. J Vasc Res (1998) 0.89
Metabolism of angiotensin I by different tissues in the intact animal. Am J Physiol (1992) 0.89
Renal hemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with hypertensive and normotensive parents. N Engl J Med (1991) 0.88
The place of renal scintigraphy in the diagnosis of renal artery stenosis. Fifteen years of clinical experience. Arch Intern Med (1997) 0.88
Increased expression of a homologue of drosophila tissue polarity gene "frizzled" in left ventricular hypertrophy in the rat, as identified by subtractive hybridization. J Mol Cell Cardiol (1996) 0.88
High-affinity prorenin binding to cardiac man-6-P/IGF-II receptors precedes proteolytic activation to renin. Am J Physiol Heart Circ Physiol (2001) 0.88
Species-dependent effect of neuromuscular blocking agents. Eur J Pharmacol (1971) 0.88
Captopril affects blood pressure equally in renovascular and essential hypertension and in the fluid-depleted anephric state. Clin Sci (Lond) (1980) 0.87
Liver blood flow measurement in the rat. The electromagnetic versus the microsphere and the clearance methods. J Pharmacol Methods (1989) 0.87
Tissue distribution of K-vitamers under different nutritional regimens in the rat. Biochim Biophys Acta (1998) 0.87
Angiogenic potential of malignant and non-malignant human breast tissues in an in vivo angiogenesis model. Int J Cancer (1998) 0.87
Preferential renal vasodilator effects of CGP 22979A in conscious spontaneously hypertensive rats. J Pharmacol Exp Ther (1985) 0.86